Katrin Preller, received her M.Sc. (Neuropsychology) from University of Konstanz, Germany. For her PhD she went to University of Zurich, Switzerland, where she investigated the neurobiological and social-cognitive long-term effects of cocaine, MDMA, and heroin use. After completing her PhD, she joined the Neuropsychopharmacology and Brain Imaging lab at the Psychiatric University Hospital Zurich, investigating the effects of psilocybin and LSD on self-perception, social cognition, and multimodal processing using different brain imaging techniques. She furthermore worked as Postdoc at the Wellcome Trust Centre for Neuroimaging, UCL, London, UK, and Yale University, New Haven, CT, USA and is currently investigating the neurobiology of psychedelics in clinical and pre-clinical studies.